Literature DB >> 16099427

Anthrax edema factor potency depends on mode of cell entry.

Jia Hong1, Jeff Beeler, Natalia L Zhukovskaya, Weisong He, Wei-Jen Tang, Marsha Rich Rosner.   

Abstract

Anthrax edema factor (EF) is a highly active calmodulin-dependent adenylyl cyclase toxin that can potently raise intracellular cAMP levels causing a broad range of tissue damage. EF needs anthrax protective antigen (PA) to enter into the host cell and together they form edema toxin. Here, we examine factors that are critical for edema toxin cell entry and potency. In Y1, 293T and mouse embryonic fibroblast cells, EF causes cell rounding, aggregation, and sometimes detachment via protein kinase A but not Epac. The rate-limiting step for these EF-mediated effects is cellular entry via the anthrax toxin receptor. Finally, EF potency is also enhanced if the EF adenylyl cyclase domain is transfected into host cells, even in the absence of the anthrax PA-binding domain. These results indicate that the effects of EF in cells can differ dependent upon the mode of cellular entry of the adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099427     DOI: 10.1016/j.bbrc.2005.07.132

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides.

Authors:  Hesham M Taha; Jennifer Schmidt; Martin Göttle; Srividya Suryanarayana; Yuequan Shen; Wei-Jen Tang; Andreas Gille; Jens Geduhn; Burkhard König; Stefan Dove; Roland Seifert
Journal:  Mol Pharmacol       Date:  2008-12-04       Impact factor: 4.436

2.  Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin.

Authors:  Yannick Trescos; Emilie Tessier; Clémence Rougeaux; Pierre L Goossens; Jean-Nicolas Tournier
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

3.  Glycogen synthase kinase 3 activation is important for anthrax edema toxin-induced dendritic cell maturation and anthrax toxin receptor 2 expression in macrophages.

Authors:  Jason L Larabee; Francisco J Maldonado-Arocho; Sergio Pacheco; Bryan France; Kevin DeGiusti; Salika M Shakir; Kenneth A Bradley; Jimmy D Ballard
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  Anthrax edema toxin sensitizes DBA/2J mice to lethal toxin.

Authors:  Aaron M Firoved; Mahtab Moayeri; Jason F Wiggins; Yuequan Shen; Wei-Jen Tang; Stephen H Leppla
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

Review 5.  Emerging themes of cAMP regulation of the pulmonary endothelial barrier.

Authors:  Sarah L Sayner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-02-18       Impact factor: 5.464

6.  Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.

Authors:  Alexandra Duverger; Jeanne-Marie Carré; Junbae Jee; Stephen H Leppla; Estelle Cormet-Boyaka; Wei-Jen Tang; Daniel Tomé; Prosper N Boyaka
Journal:  J Immunol       Date:  2010-10-15       Impact factor: 5.422

7.  Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta.

Authors:  Francisco J Maldonado-Arocho; Kenneth A Bradley
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

8.  Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.

Authors:  Qingfu Xu; Eric D Hesek; Mingtao Zeng
Journal:  Microb Pathog       Date:  2007-03-15       Impact factor: 3.738

9.  Bacillus anthracis edema toxin impairs neutrophil actin-based motility.

Authors:  Sarah E Szarowicz; Russell L During; Wei Li; Conrad P Quinn; Wei-Jen Tang; Frederick S Southwick
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

Review 10.  Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.

Authors:  Martin Göttle; Stefan Dove; Roland Seifert
Journal:  Toxins (Basel)       Date:  2012-07-06       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.